Activation of basophil and mast cell histamine release by eosinophil granule major basic protein by unknown
ACTIVATION  OF  BASOPHIL  AND  MAST  CELL  HISTAMINE 
RELEASE  BY  EOSINOPHIL  GRANULE  MAJOR  BASIC  PROTEIN* 
Be MARTHA CRAMER O'DONNELL, STEVEN J. ACKERMAN, GERALD J. 
GLEICH, AND LARRY L, THOMAS* 
From the Department of Immunology~Microbiology, Rush Medical College, Chicago, Illinois 60612; and 
the Departments of Medicine and Immunology, Mayo Medical School and Mayo Clinic and Foundation, 
Rochester, Minnesota 55901 
A  frequent  characteristic  of immediate  hypersensitivity reactions  is  systemic  or 
localized tissue eosinophilia (1). This response is attributed to mast cell and basophil 
release of acidic tetrapeptides (2-4) and other products (5) preferentially chemotactic 
for eosinophils. Because of this association and eosinophil release of histaminase  (6) 
and  other  mediators  (7,  8)  that  may  dampen  allergic  reactions,  eosinophils  are 
postulated to play an important role in the maintenance of local homeostasis during 
immediate hypersensitivity reactions (7, 8). Eosinophils and their products, however, 
are  also  recognized to  have  effector roles  in  various  host  defense mechanisms.  In 
addition to their well-described participation in anti-parasitic events (8-10), eosinophil 
participation in bactericidal (11, 12) and tumoricidal (13) mechanisms is suggested, 
Major basic protein (MBP) I is a primary constituent of eosinophil granules. MBP, 
with a  molecular weight of 9,300 in humans  (14)  and  11,000  in guinea pigs  (15), is 
localized in  the  crystalline core of the  eosinophil  granule  and  comprises >50%  of 
granule protein (16, 17). Release of MBP is implicated as a mechanism in eosinophil- 
mediated killing of parasites (18,  19) and elevated levels of MBP have been observed 
in serum of individuals with eosinophilia (20)  and at eosinophil-rich sites of inflam- 
mation  (21). A  characteristic feature of MBP is its high arginine content, ~11% for 
human MBP  (14)  and  13% for guinea pig MBP  (15). It has previously been shown 
(22) that large molecular weight polymers of basic amino acids can induce histamine 
release from human leukocytes, with polymers of L-arginine being the most potent. 
Because of its significant arginine content, we postulated that  human  MBP might 
possess similar activity. In this report, we show that  purified human MBP  induces 
noncytolytic release  of histamine  from  human  basophils.  We  confirmed  that  the 
release  is  due  to  a  direct  effect of MBP  on  basophils  using  preparations  of pure 
(92-96%)  human  basophils.  Purified  rat  peritoneal  mast  cells  display  a  similar 
response to MBP. 
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Materials and Methods 
Leukocyte Isolation.  Peripheral  blood  leukocytes were  isolated  from  the  venous blood  of 
normal human volunteers by dextran sedimentation (23). The leukocytes were washed twice at 
4°C before use in buffer containing  25 mM piperazine-N,N'-bis-(2-ethane sulfonic acid) (PIPES) 
(Sigma Chemical Co., St. Louis, MO), 150 mM NaCI, 5 mM KCI, 40 mM NaOH, and 0.003% 
human serum albumin (Calbioehem-Behring Corp., La Jolla, CA), pH  7.4 (PA).  Cells were 
pelleted between washes by centrifugation at 200 g for 10 rain at 4°C. 
Mononuclear Cell Isolation.  The basophil-eontaining  mononuclear cell fraction was isolated 
from venous blood of normal human volunteers by Ficoll-Hypaque density gradient centrifu- 
gation (24),  10-ml aliquots of blood (containing 5 mM EDTA as anticoagulant) were diluted 
with 30 ml of Hanks' balanced salt solution (Gibco Laboratories, Grand Island, NY), pH 7.35, 
containing 5 mM EDTA, 5.4  mM glucose,  and 0.1% bovine serum albumin (HEGA). The 
diluted blood was underlayed with 10 ml of Histopaque (Sigma Chemical Co.) and centrifuged 
at 400 g for 30 rain at 22°C. Cells at the plasma/Histopaque interface were removed, diluted 
1:1 with cold HEGA, and collected by eentrifugation at 400 g for 10 min at 4°C. The cell pellet 
was washed with PA as described above. This procedure yielded cell preparations containing 
1-2% basophils by staining with alcian blue (25). 
Human Basophil Purification.  Basophils were purified by flow microfluorometry according to 
the  method  of Weil et  al.  (26) as  described previously (27). Mononuclear cells  isolated as 
described  above  were  incubated  for  30  rain  at  4°C  with  a  1:50  dilution of  fluorescein 
isothiocyanate-conjugated  sheep IgG anti-human  IgE (Cappel Laboratories, Cochranville, PA). 
After washing three times at 4°C in HEGA, the cells were sorted using a fluorescence-activated 
cell sorter (FACS IV; B-D FACS Systems, Becton, Dickinson & Co., Sunnyvale, CA). The cells 
were first sorted at a rate of ~ 10,000 cells/s and then re-sorted at a rate of ~ 1,000 cells/s; ice- 
cold HEGA served as the sheath and diluting  fluid during sorting. The resultant cell preparation 
contained 92-96%  basophils by alcian blue staining (25) and by differential cell counts of 
smears fixed with Mota's fixative and stained with toluidine blue (28). The mean histamine 
contents of basophils in the mononuclear and purified ba.sophil preparations were not signif- 
icantly different, being 1.47 ±  0.14  (mean ±  SEM) and 1.59 ±  0.10 pg/basophil, respectively. 
The purified basophils were washed once at 4°C in PA before use. 
Isolation of  Rat Peritoneal  Mast Cells.  Male, 250-300-gm Sprague-Dawley rats (Locke-Erickson 
Laboratory, Oak Park, IL) were killed by ether inhalation and mast cells were collected by 
rinsing the peritoneal cavities with 20 ml of PA containing 10 U/ml of heparin (Lympho-Med 
Inc., Chicago, IL). Each experiment normally used cells pooled from two rats. Mast cells were 
purified by centrifugation through 38% (wt/vol) bovine serum albumin (Sigma Chemical Co.) 
as described by Sullivan et al. (29). The cell pellet was washed three times at 4°C in PA before 
use;  cells  were collected between washes  by centrifugation at  50 g  for  7 rain at  4°C.  The 
resultant cell preparations routinely contained >90% mast cells by toluidine blue staining, with 
cell viability >90% by trypan blue exclusion. 
Purification of MBP.  Native MBP was purified from eosinophils of patients with marked 
peripheral blood eosinophilia as described in detail elsewhere  (14). Sephadex G-50 fractions 
containing native MBP, in 0.025  M  sodium acetate column buffer, pH 4.3, were pooled and 
stored in aliquots at -70°C. The native MBP was homogenous as judged by the presence of a 
single protein band after electrophoresis on sodium dodecyl sulfate polyacrylamide gels  as 
described previously (14). Aliquots were thawed before use, and repeated freezing and thawing 
were avoided. For some experiments, reduction and alkylation of native MBP were performed 
using a 60-fold molar excess of dithiothreitol and a  120-fold molar excess of iodoacetamide as 
described elsewhere  (20). Reduction and alkylation prevents the tendency of the molecule to 
form disulfide-linked aggregates upon standing at neutral pH in the presence of oxygen (14, 
15). The reduced and alkylated MBP was dialyzed against water, lyophilized, and stored at 
-70°C. Reduced and alkylated MBP was reconstituted in PA buffer as needed and stored in 
aliquots at -70°C. Concentrations of MBP were determined by an E277 of 26.3 (14). 
Conditions for Basophil Histamine Release.  Aliquots of leukocytes or purified basophils were 
added in PA to 12- x  75-mm Falcon plastic tubes (Falcon Labware, Oxnard, CA) to give 2 × 
108 or 2 ×  104 cells per tube, respectively. The MBP or a  13,900-dalton polymer of poly-L- 
arginine (Miles Laboratories Inc., Elkhart, IN) was added in volumes not exceeding 0.06 ml O'DONNELL ET AL.  1983 
and  the  reactions  were  initiated  by  addition  in  0.01  ml  of CaCI2  and  MgCI2  to  final 
concentrations of 0.6 and  1.0 mM,  respectively. The  final incubation volume was 0.25  ml. 
Spontaneous histamine release was determined with cells incubated in the absence of stimulus. 
The influence of the 0.025 M  sodium acetate column buffer, pH 4.3, on spontaneous release 
was evaluated in experiments using native MBP. In some experiments as indicated, cells were 
preincubated with 4 mM EDTA, pH 7.35, or 3 mM 2-deoxy-D-glucose (Sigma Chemical Co.) 
for  10 rain at 37°C before addition of the stimulus. Cells were incubated for 45 rain, or for 
times indicated, at 37°C in an oscillating water bath. Reactions were stopped by addition of 
0.25 ml cold PA and centrifuged for 2 min at  1,000 g. The histamine content of the cell-free 
supematants was determined by the automated fluorometric procedure of Siraganian (30), with 
the total cellular histamine content determined in supernatants of cells lysed with 2% perehloric 
acid. Results are expressed as the net percent histamine release. Spontaneous release was always 
<10%  for  peripheral  leukocytes and  mononuclear  cells and  <15%  for  purified  basophils. 
Because of the limited quantities of MBP, initial experiments using MBP were done in duplicate 
and subsequent experiments were done using single determinations; experiments using purified 
basophils were also done using single determinations. All other experimental determinations 
were done in duplicate, with <5% variation in the values for duplicate histamine determinations. 
Conditions for Histamine Release  from Rat Mast Cells.  Aliquots containing 1.5 x  104 mast cells 
in PA were added to  12- X  75-ram Falcon plastic tubes, and MBP, poly-L-arginine, 0.025  M 
sodium acetate buffer, pH 4.3, or PA were added as described above to a final volume of 0.25 
ml. Compound 48/80  (Sigma Chemical Co.) was used as a positive control stimulus with rat 
mast cells. After the addition of 0.6 mM CaC12 and 1 mM MgC12 to the incubation contents as 
above, the cells were incubated for  10 min, or as indicated, at  37°C.  The remainder of the 
protocol is as described for the human cell preparations. 
Results 
Concentration Requirements and Kinetics of MBP-stimulated Histamine Release.  Incubation 
of peripheral  leukocytes with  5  X  10  -7  to  7.5  X  10  -e M  native  MBP  produced  a 
marked and concentration-dependent histamine release. Results of four experiments, 
each using leukocytes of a  different donor, are shown in Fig. 1. Release by leukocytes 
incubated  with  volumes of 0.025  M  sodium  acetate buffer,  pH  4.3,  equal  to  those 
required  for  MBP  addition  did  not  exceed  spontaneous  release  by  >4%  in  any 
experiment.  Leukocyte  sensitivity to  MBP  differed  for  individual  donors,  but  the 
response  of cells  from  the  same  donor  remained  similar  in  repeated  experiments. 
Histamine  release  values  of  58,  63,  72,  and  61%  were  obtained  in  four  separate 
experiments using leukocytes of the same donor and 3.7  X  10 -e M  native MBP.  An 
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Fio.  1.  Stimulation of histamine release  from  peripheral leukocytes by native MBP.  Results 
obtained with leukocytes of four donors in four separate experiments are shown. Histamine release 
values for the donor denoted by the open circles are the means of duplicate measurements. All other 
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examination of the kinetics for release caused by 3.7 ×  10 -6 M  native MBP indicated 
that release increased with time for ~40 rain (Fig. 2); half-maximal secretion occurred 
at ~  17 min. Similar kinetics were obtained with leukocytes of an additional donor. 
Comparison  of  Native  MBP  with  Reduced  and  Alkylated  MBP  and  Poly-L- 
Arginine.  Concentrations  of native  MBP  required  for release were compared  with 
those for reduced and alkylated MBP and the  13,900-dalton  poly-L-arginine.  Repre- 
sentative results obtained with leukocytes of two donors are shown in Fig. 3. Optimal 
concentrations for native MBP were within the concentration range of 10 -6 to 5.7  × 
10 -6 M, whereas poly-L-arginine induced  comparable levels of release at Concentra- 
tions of 6  X  10 -6 to 2  X  10 -7  M.  After reduction and alkylation, the concentration 
curve  for  MBP  shifted  ~  1  log  to  the  right  and  the  maximum  histamine  release 
obtained seldom surpassed 40%.  In some instances, release caused by higher concen- 
trations of reduced and alkylated MBP plateaued or even decreased (data not shown). 
Similar release profiles were noted with at least five additional donors each for poly- 
L-arginine  and  the  reduced  and  alkylated  MBP,  although  leukocytes of individual 
donors also differed in their sensitivity to these stimuli. In those experiments, release 
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Fxo.  2.  Kinetics  of  native  MBP-stimulated  histamine  release  from  peripheral  leukocytes.  The 
reaction  was initiated  by addition  of 3.7 ×  10  -n M  native MBP at  time  zero and stopped  at  the 
times indicated by addition of 4 mM EDTA and removal of the cells by centrifugation.  Each point 
represents a single experimental  value. 
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Fio.  3.  Concentration requirements for stimulation of histamine release from peripheral leukocytes 
by native MBP, reduced and alkylated MBP, and poly-L-arginine.  Leukocytes were incubated with 
native  MBP  (circles),  reduced  and  alkylated  MBP  (squares), or poly-L-arginine  (triangles)  in  the 
same experiment.  Open  and filled symbols indicate results obtained  with leukocytes of two donors 
in separate experiments.  Values  depicted  for poly-L-arginine  as well as the values  denoted  by the 
open symbols for the MBP preparations are the means of duplicate determinations;  all other points 
represent a single experimental  value. The results presented for native MBP are included in Fig.  I. O'DONNELL ET AL.  1985 
caused by 2 X  10  -7 M  poly-L-arginine ranged from 29 to 64% (n =  7), whereas release 
with 4.6 X  10  -5 M  reduced and alkylated MBP ranged from I3 to 29% (n -- 5). 
Evaluation of Release Mechanism.  Because  reduced  and  alkylated  MBP  has  been 
shown to be cytotoxic for some mammalian  cells  (18,  31), the calcium and energy 
requirements for native MBP-induced histamine release from human leukocytes were 
determined to assess  a possible lytic effect of MBP on basophils (Fig. 4). Omission of 
calcium from the incubation buffer, together with addition of 4 mM EDTA, blocked 
the concentration-dependent increases in histamine release caused by native MBP. 
Release was  similarly  inhibited  by preincubation of the  leukocytes with  3  mM  2- 
deoxy-D-glucose. Temperature dependence was also demonstrated by the failure of 
native MBP  to stimulate  histamine release when  incubated with  the cells at  4°C. 
Calcium  depletion  or  preincubation  with  2-deoxy-D-glucose  similarly  inhibited 
(>88%)  release from leukocytes of two additional donors and one additional donor, 
respectively, during incubation with 3.7 ×  10  -6 M  native MBP. Similar calcium and 
energy dependence was also noted with reduced and alkylated MBP in two separate 
experiments. 
Histamine Release  from Purified Basophils.  To establish that the histamine release was 
due to a direct effect of MBP on basophils, three experiments were performed using 
preparations of pure (92-96%) human basophils. Incubation with  1.9 ×  10  -6 and 3.7 
X  10  -6 M  native MBP resulted in 7-71% histamine release in the three experiments 
(Table I). Comparable release was obtained with aliquots of the mononuclear cell 
preparations from which the basophils had been purified; the control mononuclear 
cells were held at 4°C in HEGA during purification of the remaining cells. Release 
with 0.025 M  sodium acetate buffer, pH 4.3, never exceeded spontaneous release by 
>6% for either cell preparation. In results not shown, incubation at 4°C completely 
abrogated the response of each cell preparation to 3.7 ×  10  -6 M  native MBP in each 
experiment.  The  results  presented  in  Table  I  also  demonstrate  that  reduced  and 
alkylated  MBP  and  poly-L-arginine  each  initiate  histamine  release  by  a  direct 
influence on basophils. The relative concentration requirements of the three stimuli 
with the purified basophil preparations were similar to those observed with peripheral 
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FIG.  4.  Calcium, energy, and temperature dependence of native MBP-induced histamine release 
from peripheral leukoeytes. Cells were preincubated with 4 mM EDTA or 2-deoxy-n-glucose for 10 
rain at  37°C before addition of the indicated concentrations of native MBP.  Solid bars indicate 
MBP alone. Open bars indicate MBP plus 4  mM EDTA and no Ca  2+. Hatched bars show MBP 
plus 3 mM 2-deoxy-n-glucose. Stipled bars show cells incubated with MBP for 45 rain at 4°C. Each 
value represents a single experimental determination. 1986  ACTIVATION  OF  BASOPHIL  AND  MAST  CELL  HISTAMINE  RELEASE 
TAeLE  I 
Stimulation of Histamine Release  from Purified Human Basophils by MBP and Poly-L-Arginine 
Percent histamine release 
Stimulus  Experiment 1  Experiment 2  Experiment 3 
Mononu-  Baso-  Mononu-  Baso-  Mononu-  Baso- 
clear cells  phils  clear cells  phils  clear cells  phils 
Native MBP 
1.9 X  10-6M  28  7  45  55  58  46 
3.7 ×  10-6M  32  15  47  71  63  32 
Reduced and alkylated MBP 
2.4 X  10  -~ M  ND  ND  ND  20  ND  12 
4.6 X  10  -5 M  ND  ND  ND  30  ND  24 
Poly-L-Ar~nine 
1X  10-TM  14  63  45  64  65  56 
2 X  IO-~M  45  72  61  67  75  60 
Human basophils purified by flow microfiuorometry and control aliquots of the mononuclear cells from 
which the basophils had been purified were incubated for 45 min at 37°C with the indicated concentrations 
of native MBP, reduced and alkylated MBP, or poly-L-arginine. Each value represents a  single determi- 
nation. Experiments 2 and 3 were done using cells isolated from the same donor. Spontaneous histamine 
release values in the three experiments were 15, 14, and 12% for the basophil preparations and 5, 6, and 8% 
for the mononuclear cell preparations. ND, not determined. 
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FIe.  5.  Histamine release from purified rat mast cells. Rat mast cells were incubated with poly- 
L-arginine (filled symbols) or native human MBP  (open symbols) for  10 min at 37°C.  Results of 
three experiments are shown. Values shown for poly-L-arginine represent the means of duplicate 
determinations. 
leukocytes (of. Fig. 3). 
Histamine Release  from Purified Rat Mast Cells.  Polycation-induced histamine secre- 
tion  from rat  mast  cells is  complete within  10 rain  at  37°C  and  does not  require 
exogenous phosphatidyl serine (32-34). Incubating rat mast cells (>90% purity) with 
native human MBP and poly-L-arginine under these conditions resulted in a concen- 
tration-dependent histamine release similar to that observed with human leukocytes. 
Results  of three experiments are shown  in  Fig.  5.  The concentrations that  caused 
release  from  rat  mast  cells  closely approximated  the  concentrations  that  induced 
release from human leukocytes. Spontaneous release in the three experiments was 9, 
8, and  14%; release caused by 0.1 #g/ml of compound 48/80 in the three experiments O'DONNELL ET  AL.  1987 
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Fro.  6.  Kinetics of MBP-stimulated histamine release from purified rat mast cells. Reactions were 
initiated by addition of 3.7 ×  10  -6 M  native human MBP at time zero. Reactions were stopped by 
addition  of ice-cold  PA  and centrifugation for 2  min at  1,000 g.  Each  point  represents a  single 
experimental value. 
was 71,  75, and 27%. The apparently depressed response to native MBP and poly-L- 
arginine in the experiment denoted by the square symbols in Fig. 5 correlated with a 
higher spontaneous release and reduced response to 48/80. The concentration curve 
for  poly-L-arginine obtained  with  rat  mast  ceils  was  somewhat  flatter  than  that 
observed with human leukocytes, whereas native MBP gave a rather steep concentra- 
tion curve with either cell preparation. 
A  closer examination of the time course for release demonstrated that histamine 
release caused by native MBP was essentially complete after incubation for 1 min at 
37°C (Fig. 6). Similar kinetics were obtained in a second experiment with native MBP 
and in two additional experiments with poly-L-arginine. Cell viability, as measured 
by trypan blue (0.05%)  exclusion, was not altered significantly after incubation with 
1-2 ×  10  -6 M  native MBP and release of >70% of the histamine content. Although 
extensive degranulation was evident, cell viability remained 80 4- 6% (mean 4- SD; n 
=  6); the viability of cells incubated in buffer only (<10% histamine release) was 86 
4-  5%  in the same experiments. In  results  not  shown,  the addition  of 40 #g/ml  of 
phosphatidyl serine did not enhance the response to poly-L-arginine, a finding similar 
to that reported for compound 48/80 (33). 
Discussion 
These  results  demonstrate  that  native  MBP  purified  from  human  eosinophil 
granules  initiates  a  concentration-dependent,  noncytolytic histamine  release  from 
human leukocytes and purified rat mast cells. Furthermore, the results obtained using 
purified basophils indicate that the release from human leukocytes is due to a direct 
influence of MBP on basophils. Previous studies have demonstrated that reduced and 
alkylated MBP is cytotoxic for schistosomula and larvae of helminths  (18,  19)  and 
also mammalian cells (18, 31) during prolonged (>18 or >4 h, respectively) incuba- 
tion. The release of histamine  from human  basophils  by similar  concentrations of 
reduced and alkylated MBP and also by native MBP, however, occurs within 45 min 
of incubation. More importantly, release with both MBP preparations exhibited the 
calcium  and  metabolic  energy  requirements  as  well  as  temperature  dependence 
characteristic  of secretory processes  (35).  The  absence  of a  significant  increase  in 
trypan blue staining  after stimulation  of rat  mast  cells with native MBP provides 1988  ACTIVATION  OF BASOPHIL AND MAST CELL HISTAMINE RELEASE 
further evidence for a  noncytolytic release mechanism. Of particular significance is 
the finding that native MBP was ~ 10-fold more potent than reduced and alkylated 
MBP as a  stimulus  for histamine release. This is the first occasion in which native 
MBP has been observed to be more potent than the reduced and alkylated form of 
MBP. 
Although  the  mechanism  for  MBP-stimulated  histamine  release  from  human 
basophils  has  yet  to  be  determined,  the  similarities  to  poly-L-arginine-stimulated 
release suggest that it is related to the polycationic nature of the molecule. In addition 
to sharing a  noncytotoxic mechanism, the kinetics for release by optimal concentra- 
tions of native MBP closely approximate those reported for poly-L-arginine (22)  and 
are  slower  than  the  rate  of IgE-mediated  release  (23).  The  mechanism  of poly-L- 
arginine-stimulated  release  has  previously  been  shown  to  be  independent  of IgE 
antibody  (22).  Stimulation  of histamine  release  by  MBP  from  basophils  purified 
under  conditions  known  to  desensitize  basophils  to  IgE-mediated  stimuli  (36)  is 
consistent with this finding. Although native MBP is less potent than poly-L-arginine 
molecules of similar molecular weight, this difference may reflect the lower arginine 
content  (11%)  of human  MBP  (14).  Foreman and  Lichtenstein  (22)  demonstrated 
that  the potency of polymer amino  acids  is  influenced by the chain  length  of the 
polymer, a finding they interpreted to indicate the importance of the number of free 
amino  groups,  or  effective  positive  charge,  of the  polymer.  We  found  in  other 
experiments  2 that the 13,900-dalton polymer of L-arginine is approximately one-fifth 
less  potent than  the 60,000-dalton polymer used in the earlier study  (22), which is 
consistent with the interpretation of Foreman and Lichtenstein. A polycationic basis 
for the release was further reinforced by the findings that native MBP also induced 
histamine secretion from purified rat mast cells. Both the kinetics of release and the 
absence of a  phosphatidyl serine requirement are characteristic of polycation-stimu- 
lated secretion (32-34). The much-reduced potency of low molecular weight polymers 
of L-lysine  2 (30,000 daltons)  and the inability of other polycations such as histones, 
spermine, and protamine to stimulate histamine release from leukocytes (22) indicate, 
however, that release by native MBP cannot be solely attributed to the net positive 
charge of the molecule. The findings presented here that reduction and alkylation of 
MBP reduce both the potency and efficacy of the molecule suggest a conformational 
requirement. 
Based on the frequent association of eosinophilia and IgE-mediated hypersensitivity 
reactions  (1)  and  the  cellular  distribution  of specific  mediators  (2-6)  described 
previously, a  mast  cell/basophil-eosinophil regulatory axis has been constructed in 
which a primary role of eosinophils is to dampen immediate hypersensitivity reactions 
(7, 8). That eosinophils may, however, also potentiate basophil and mast cell functions 
is shown by findings that relatively low concentrations of eosinophil peroxidase in the 
presence of hydrogen peroxide and a halide induce noncytotoxic degranulation of rat 
peritoneal mast cells (37)  and also enhance mast cell tumoricidal activity (38). The 
results presented here extend possible activation by eosinophils to include the effect 
of MBP on human basophils and also rat mast cells.  Importantly, concentrations of 
native MBP that initiated histamine release were similar to concentrations measured 
in serum of atopic patients with eosinophilia (20) and in sputum of asthmatic patients 
(39). With an influx of eosinophils into sites of immediate hypersensitivity reactions, 
O'Donnell, M. C., L. Potempa, H. Gewurz,  and L. L. Thomas. Manuscript in preparation. O'DONNELL ET AL.  1989 
the  release of MBP  from eosinophils could prolong the basophil-mediated  release 
events. It is not known whether the findings presented here can be extended to human 
mast  cells.  It  has  recently  been  reported  (40)  that  human  lung  mast  cells  are 
unresponsive to a  60,000-dalton polymer of L-arginine in concentrations that were 
optimal for the 13,900-dalton polymer in the present study. 
The  implications  for an  effect of MBP  on  human  basophils  are  not  limited  to 
allergic reactions. Infiltrates of eosinophils and basophils have recently been described 
in lesions of bullous pemphigoid  (41). Basophil degranulation was observed that  is 
consistent with the kinetics of MBP-stimulated histamine release reported here; the 
presence of MBP in lesions of bullous pemphigoid has also been documented (42). 
Basophil activation by MBP may also have important  implications for eosinophil- 
mediated host defense roles. Mast  cell products including histamine and the acidic 
tetrapeptides have been reported to enhance both antibody-dependent and comple- 
ment-dependent  killing  of schistosomula  (43,  44).  A  requirement  for  circulating 
basophils in the protection of guinea pigs against tick infection has also been described 
recently (45). The ability of native MBP to stimulate basophil mediator release may 
facilitate the destruction and elimination of parasitic organisms by eosinophils. 
Thus,  it is becoming apparent that  the interaction of eosinophils with  basophils 
and mast cells is bidirectional and that interaction in either direction is important to 
the maintenance of local homeostasis. 
Summary 
Major basic protein (MBP) is a primary constituent of eosinophil granules. In this 
report, we demonstrate that MBP from human eosinophil granules initiates a nonlytic 
histamine release from human leukocytes. A  direct effect of MBP on basophils was 
confirmed using purified human  basophils.  The kinetics of release were similar to 
those reported for poly-L-arginine, although MBP was less potent than poly-L-arginine 
of similar molecular weight. Reduction and alkylation of MBP diminished both the 
potency and efficacy of the molecule. Native MBP also stimulated histamine secretion 
from purified rat peritoneal mast cells in a manner characteristic of other polycations. 
These results emphasize the bidirectional nature of the basophil/mast cell-eosinophil 
regulatory axis. 
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